NCT00963690View on ClinicalTrials.gov

Evaluation of the CloSys Closure System as an Adjunct to Standard Compression

NATerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

April 30, 2013

Study Completion Date

May 30, 2013

Conditions
Sealing the Arteriotomy
Interventions
DEVICE

CloSys Hemostatic Device (HD)

Deploy CloSys HD to achieve hemostasis

PROCEDURE

Standard compression

Use standard compression to achieve hemostasis

Trial Locations (2)

27607

Rex Healthcare - Rex Heart and Vascular Research, Raleigh

70506

Cardiovascular Institute of the South, Lafayette

Sponsors

Lead Sponsor

CloSys Corporation
All Listed Sponsors
collaborator

Eminence Clinical Research, Inc.

INDUSTRY

lead

CloSys Corporation

INDUSTRY

NCT00963690 - Evaluation of the CloSys Closure System as an Adjunct to Standard Compression | Biotech Hunter | Biotech Hunter